The Relationship Between Metabolic Syndrome and Benign Prostate Enlargement: A Case–Control Study in a Peruvian Military Hospital
Urology Research and Practice · 10.03.2023 · 49 (1) · 19-24
DOI: 10.5152/tud.2023.22236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urology Research and Practice, online erschienen am 10.03.2023. Verfasst von Valeria Ugarte-Carbajal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones en Ciencias Biomédicas, Universidad Ricardo Palma, Lima-Peru. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study aimed to determine how metabolic syndrome is related to benign prostatic enlargement in males under 60 years old in a national military hospital in Peru. Materials and methods: We conducted a retrospective, quantitative, case–control study. By simple random sampling, 87 cases with benign prostatic enlargement and 174 controls were included, with a statistical power of 80%. The benign prostatic enlargement was evaluated by clinical picture and ultrasound and the metabolic syndrome was evaluated according to the Adult Treatment Panel III criteria. The statistical analysis was performed using the STATAv14 program, the chi-square statistical test was used and odds ratio was obtained, at a significance level of 5%.
Results
The mean age of the cases and controls was 55 (51-58) and 52 (46-57), respectively. By multivariate analysis, the factors related to benign prostatic enlargement were the presence of benign prostatic enlargement (adjusted odds ratio: 2.71, 95% CI: 1.27-5.80; P=.010), waist circumference ≥102 cm (adjusted odds ratio: 6.51, 95% CI: 3.09-13.71; P < .001), elevated fasting glucose (adjusted odds ratio: 1.38, 95% CI: 0.65-2.91; P=.399), high triglycerides (adjusted odds ratio: 5.29, 95%: CI 2.40-11.64; P < .001), and arterial hypertension (adjusted odds ratio: 4.67, 95% CI 2.19-9.95; P < .001). Elevated high-density lipoprotein cholesterol was a protective factor (adjusted odds ratio: 0.09, 95% CI: 0.04-0.20; P < .001).
Conclusion
The present study showed that metabolic syndrome and its components (waist circumference, hypertension, triglycerides, and high-density lipoprotein cholesterol) are factors related to benign prostatic enlargement in patients under 60 years old in a military hospital in Peruvian population. Waist circumference as an indicator of overweight/obesity is a practical anthropometric marker of interest in public health. Cite this article as: Ugarte-Carbajal V, Vela-Ruiz JM, Guillen-Ponce R, CorreaLópez LE, Rubin-de-Celis V, De La Cruz-Vargas JA. The relationship between metabolic syndrome and benign prostate enlargement: A case–control study in a peruvian military hospital. Urol Res Pract., 2023;49(1):19-24.
Autor:innen und Institutionen
- Instituto de Investigaciones en Ciencias Biomédicas, Universidad Ricardo Palma, Lima-Peru.
- Instituto de Investigaciones en Ciencias Biomédicas, Universidad Ricardo Palma, Lima-Peru;Lifestyle Medicine Department, Universidad Ricardo Palma, Lima-Peru.
Zitieren
APA
Ugarte-Carbajal, V., Vela-Ruiz, J. M., Guillen-Ponce, V. R., Correa-López, L. E., Rubin-de-Celis, V., & Cruz-Vargas, J. A. (2023). The Relationship Between Metabolic Syndrome and Benign Prostate Enlargement: A Case–Control Study in a Peruvian Military Hospital. Urology Research and Practice, 49(1), 19-24. https://doi.org/10.5152/tud.2023.22236
Vancouver
Ugarte-Carbajal V, Vela-Ruiz JM, Guillen-Ponce VR, Correa-López LE, Rubin-de-Celis V, Cruz-Vargas JA. The Relationship Between Metabolic Syndrome and Benign Prostate Enlargement: A Case–Control Study in a Peruvian Military Hospital. Urology Research and Practice. 2023;49(1):19-24. doi:10.5152/tud.2023.22236
BibTeX
@article{UgarteCarbajal2023,
author = {Ugarte-Carbajal, Valeria and Vela-Ruiz, José M and Guillen-Ponce, Vela-Rui and Correa-López, Lucy E and Rubin-de-Celis, Verónica and Cruz-Vargas, Jhony A De La},
title = {The Relationship Between Metabolic Syndrome and Benign Prostate Enlargement: A Case–Control Study in a Peruvian Military Hospital},
journal = {Urology Research and Practice},
year = {2023},
volume = {49},
number = {1},
pages = {19--24},
doi = {10.5152/tud.2023.22236}
}
EUVIMED